Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02974335 · ClinicalTrials.gov registry record
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 1
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 67
- Enrollment target
NCT02974335 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 67 participants.
The verdict
NCT02974335 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
Study Summary
This is a 4-phase study to implement the NIDA CDEs in primary care settings. Collecting and utilizing the CDEs in clinical practice requires a strategy for implementing screening to collect substance use information that populates the CDEs, and assisting primary care providers to offer appropriate interventions by providing clinical decision support (CDS) and a mechanism for making referrals to addiction treatment. We aim to maximize the efficient adoption of screening, CDS, and treatment referrals by integrating all of these activities into the electronic health record (EHR). The study will be conducted at three sites, representing three large health systems. Each phase will include deliverables essential to move to the next phase, and an independent Advisory Committee will review progress and make recommendations at each transition about how best to progress to each subsequent phase. Based on progress during earlier phases, the Advisory Committee may recommend expansion to additional clinics or health systems during the second part of Phase 4.
Interventions
- BEHAVIORAL Interviews with Stakeholders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2017-07-25 |
| Est. Completion | 2019-04-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02974335
The ClinicalTrials.gov registry entry for NCT02974335 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Interviews with Stakeholders is the first listed.
NCT02974335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02974335 about?
NCT02974335 is a clinical study titled "A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 1". This is a 4-phase study to implement the NIDA CDEs in primary care settings. Collecting and utilizing the CDEs in clinical practice requires a strategy for implementing screening to collect substance use information that populates the CDEs, and assisting primary care providers to offer appropriate i...
What is the current status of trial NCT02974335?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2017-07-25. Estimated completion is 2019-04-05.
What interventions are being tested in trial NCT02974335?
The interventions under investigation include: Interviews with Stakeholders (BEHAVIORAL).
Who is sponsoring clinical trial NCT02974335?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.